Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 3,217	$ 93
Vendor advances	1,515
Prepaid expenses and other current assets	10	8
Total Current Assets	4,742	101
Deferred offering costs		482
Intangible assets, net	262	382
Total Other Assets	262	864
TOTAL ASSETS	5,004	965
Current Liabilities
Accounts payable and accrued expenses	1,530	2,401
Total Current Liabilities	1,672	2,405
Convertible notes payable, net of debt discount of $105 at December 31, 2023		638
Total Liabilities	1,672	3,043
COMMITMENTS AND CONTINGENCIES - NOTE 7
Shareholders’ Equity (Deficit)
Preferred stock, par value $0.001, 20,000,000 shares authorized; no shares issued and outstanding, respectively;
Common stock, par value $0.001, 100,000,000 shares authorized; 12,846,785 and 10,562,640 shares issued and outstanding, respectively;	13	11
Additional paid-in capital	11,154	4,123
Accumulated deficit	(7,835)	(6,212)
Total Shareholders’ Equity (Deficit)	3,332	(2,078)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)	5,004	965
Related Party [Member]
Current Liabilities
Due to related parties		4
Officer [Member]
Current Liabilities
Notes payable - officers	$ 142